Anticipating The Unknowns: The Importance Of Partnership And Optimizing Your Process

Are you looking to speed up and scale out your cell therapy outcomes?

Do you have media development challenges that need to be improved?

In recent years, there has been a significant increase in Advanced Cell Therapies (ACT), which have the potential to transform the treatment of a number of diseases, such as cancer, genetic conditions, and degenerative diseases.

For the purposes of this panel review, we approaching these developments- and production-related challenges from a cell culture media perspective and highlighting its importance as a critical ancillary material throughout the development, manufacturing, and scale-up of ACTs.

Making the right decision the first time on in the process can help to save valuable time, money, and resources, especially when transitioning into the clinical trial phase and further scale-up.

Join us and our panel of experts as we discuss the challenges cell therapy developers have and solutions that can help speed time to market and remove bottlenecks before they happen.

Part 1: Anticipating the Unknown: Current Challenges in Cell Culture Development and processes and the importance of Partnership and Collaboration.

What are the key factors to consider when selecting a cell culture reagents producer for a partnership?​

How can a partnership with a cell culture media manufacturer help optimize your application?​

What are some of the challenges that companies face when scaling up, and how can partnerships with cell culture media and protein producers help overcome these challenges?​

What are some of the latest trends in CGT, and how can companies stay ahead of the curve?​

Part 2: The panel answers audience questions with an interactive Q&A.